Logo image of CTRA

COTERRA ENERGY INC (CTRA) Stock Fundamental Analysis

USA - NYSE:CTRA - US1270971039 - Common Stock

22.8 USD
+0.22 (+0.97%)
Last: 10/17/2025, 8:04:34 PM
22.8 USD
0 (0%)
After Hours: 10/17/2025, 8:04:34 PM
Fundamental Rating

6

CTRA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While CTRA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CTRA is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, CTRA could be worth investigating further for value and growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CTRA was profitable.
In the past year CTRA had a positive cash flow from operations.
CTRA had positive earnings in each of the past 5 years.
CTRA had a positive operating cash flow in each of the past 5 years.
CTRA Yearly Net Income VS EBIT VS OCF VS FCFCTRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B 5B

1.2 Ratios

The Return On Assets of CTRA (6.57%) is better than 73.46% of its industry peers.
CTRA's Return On Equity of 10.82% is fine compared to the rest of the industry. CTRA outperforms 63.98% of its industry peers.
With a decent Return On Invested Capital value of 7.30%, CTRA is doing good in the industry, outperforming 65.88% of the companies in the same industry.
CTRA had an Average Return On Invested Capital over the past 3 years of 12.27%. This is significantly below the industry average of 21.53%.
The last Return On Invested Capital (7.30%) for CTRA is well below the 3 year average (12.27%), which needs to be investigated, but indicates that CTRA had better years and this may not be a problem.
Industry RankSector Rank
ROA 6.57%
ROE 10.82%
ROIC 7.3%
ROA(3y)11.08%
ROA(5y)8.7%
ROE(3y)17.66%
ROE(5y)14.37%
ROIC(3y)12.27%
ROIC(5y)9.93%
CTRA Yearly ROA, ROE, ROICCTRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

CTRA has a better Profit Margin (23.80%) than 79.15% of its industry peers.
CTRA's Profit Margin has declined in the last couple of years.
CTRA's Operating Margin of 31.25% is fine compared to the rest of the industry. CTRA outperforms 75.83% of its industry peers.
CTRA's Operating Margin has declined in the last couple of years.
CTRA's Gross Margin of 82.52% is amongst the best of the industry. CTRA outperforms 91.94% of its industry peers.
In the last couple of years the Gross Margin of CTRA has grown nicely.
Industry RankSector Rank
OM 31.25%
PM (TTM) 23.8%
GM 82.52%
OM growth 3Y-19.39%
OM growth 5Y-9.76%
PM growth 3Y-15.14%
PM growth 5Y-9.04%
GM growth 3Y1.7%
GM growth 5Y3.22%
CTRA Yearly Profit, Operating, Gross MarginsCTRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CTRA is still creating some value.
CTRA has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CTRA has been increased compared to 5 years ago.
The debt/assets ratio for CTRA is higher compared to a year ago.
CTRA Yearly Shares OutstandingCTRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CTRA Yearly Total Debt VS Total AssetsCTRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 2.05 indicates that CTRA is not a great score, but indicates only limited risk for bankruptcy at the moment.
CTRA has a Altman-Z score of 2.05. This is in the better half of the industry: CTRA outperforms 66.82% of its industry peers.
CTRA has a debt to FCF ratio of 2.83. This is a good value and a sign of high solvency as CTRA would need 2.83 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.83, CTRA is doing good in the industry, outperforming 77.73% of the companies in the same industry.
CTRA has a Debt/Equity ratio of 0.29. This is a healthy value indicating a solid balance between debt and equity.
CTRA's Debt to Equity ratio of 0.29 is fine compared to the rest of the industry. CTRA outperforms 62.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.83
Altman-Z 2.05
ROIC/WACC0.91
WACC8.04%
CTRA Yearly LT Debt VS Equity VS FCFCTRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 1.13 indicates that CTRA should not have too much problems paying its short term obligations.
CTRA's Current ratio of 1.13 is in line compared to the rest of the industry. CTRA outperforms 47.87% of its industry peers.
CTRA has a Quick Ratio of 1.08. This is a normal value and indicates that CTRA is financially healthy and should not expect problems in meeting its short term obligations.
CTRA has a Quick ratio (1.08) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.13
Quick Ratio 1.08
CTRA Yearly Current Assets VS Current LiabilitesCTRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.00% over the past year.
CTRA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.12% yearly.
The Revenue has grown by 17.10% in the past year. This is quite good.
CTRA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.44% yearly.
EPS 1Y (TTM)10%
EPS 3Y-5.3%
EPS 5Y0.12%
EPS Q2Q%29.73%
Revenue 1Y (TTM)17.1%
Revenue growth 3Y16.53%
Revenue growth 5Y21.44%
Sales Q2Q%54.6%

3.2 Future

CTRA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.42% yearly.
The Revenue is expected to grow by 16.63% on average over the next years. This is quite good.
EPS Next Y51.91%
EPS Next 2Y42.46%
EPS Next 3Y29.11%
EPS Next 5Y14.42%
Revenue Next Year40.56%
Revenue Next 2Y23.17%
Revenue Next 3Y16.63%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CTRA Yearly Revenue VS EstimatesCTRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
CTRA Yearly EPS VS EstimatesCTRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4

8

4. Valuation

4.1 Price/Earnings Ratio

CTRA is valuated reasonably with a Price/Earnings ratio of 10.91.
CTRA's Price/Earnings ratio is a bit cheaper when compared to the industry. CTRA is cheaper than 70.14% of the companies in the same industry.
When comparing the Price/Earnings ratio of CTRA to the average of the S&P500 Index (27.40), we can say CTRA is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 6.65, the valuation of CTRA can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CTRA indicates a rather cheap valuation: CTRA is cheaper than 88.15% of the companies listed in the same industry.
CTRA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 10.91
Fwd PE 6.65
CTRA Price Earnings VS Forward Price EarningsCTRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

72.51% of the companies in the same industry are more expensive than CTRA, based on the Enterprise Value to EBITDA ratio.
69.19% of the companies in the same industry are more expensive than CTRA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.76
EV/EBITDA 5.17
CTRA Per share dataCTRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CTRA may justify a higher PE ratio.
A more expensive valuation may be justified as CTRA's earnings are expected to grow with 29.11% in the coming years.
PEG (NY)0.21
PEG (5Y)91.85
EPS Next 2Y42.46%
EPS Next 3Y29.11%

5

5. Dividend

5.1 Amount

CTRA has a Yearly Dividend Yield of 3.68%.
Compared to an average industry Dividend Yield of 6.15, CTRA has a dividend in line with its industry peers.
CTRA's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.68%

5.2 History

The dividend of CTRA is nicely growing with an annual growth rate of 18.85%!
CTRA has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)18.85%
Div Incr Years0
Div Non Decr Years0
CTRA Yearly Dividends per shareCTRA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

41.69% of the earnings are spent on dividend by CTRA. This is a bit on the high side, but may be sustainable.
CTRA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP41.69%
EPS Next 2Y42.46%
EPS Next 3Y29.11%
CTRA Yearly Income VS Free CF VS DividendCTRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B
CTRA Dividend Payout.CTRA Dividend Payout, showing the Payout Ratio.CTRA Dividend Payout.PayoutRetained Earnings

COTERRA ENERGY INC

NYSE:CTRA (10/17/2025, 8:04:34 PM)

After market: 22.8 0 (0%)

22.8

+0.22 (+0.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners94.45%
Inst Owner Change0%
Ins Owners0.87%
Ins Owner Change-1.63%
Market Cap17.40B
Analysts81.94
Price Target33.62 (47.46%)
Short Float %4.05%
Short Ratio4.61
Dividend
Industry RankSector Rank
Dividend Yield 3.68%
Yearly Dividend0.84
Dividend Growth(5Y)18.85%
DP41.69%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-14 2025-08-14 (0.22)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.37%
Min EPS beat(2)-1.36%
Max EPS beat(2)4.09%
EPS beat(4)2
Avg EPS beat(4)1.6%
Min EPS beat(4)-7.3%
Max EPS beat(4)10.97%
EPS beat(8)4
Avg EPS beat(8)2.93%
EPS beat(12)8
Avg EPS beat(12)5.11%
EPS beat(16)10
Avg EPS beat(16)2.06%
Revenue beat(2)1
Avg Revenue beat(2)3.87%
Min Revenue beat(2)-5.32%
Max Revenue beat(2)13.06%
Revenue beat(4)3
Avg Revenue beat(4)2.74%
Min Revenue beat(4)-5.32%
Max Revenue beat(4)13.06%
Revenue beat(8)5
Avg Revenue beat(8)0.75%
Revenue beat(12)8
Avg Revenue beat(12)1.3%
Revenue beat(16)10
Avg Revenue beat(16)0.7%
PT rev (1m)-0.75%
PT rev (3m)-0.05%
EPS NQ rev (1m)-1.22%
EPS NQ rev (3m)-18.86%
EPS NY rev (1m)-0.98%
EPS NY rev (3m)-7.79%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)-2.96%
Revenue NY rev (1m)-0.34%
Revenue NY rev (3m)1.28%
Valuation
Industry RankSector Rank
PE 10.91
Fwd PE 6.65
P/S 2.63
P/FCF 11.76
P/OCF 5.03
P/B 1.19
P/tB 1.19
EV/EBITDA 5.17
EPS(TTM)2.09
EY9.17%
EPS(NY)3.43
Fwd EY15.04%
FCF(TTM)1.94
FCFY8.51%
OCF(TTM)4.54
OCFY19.89%
SpS8.68
BVpS19.08
TBVpS19.08
PEG (NY)0.21
PEG (5Y)91.85
Profitability
Industry RankSector Rank
ROA 6.57%
ROE 10.82%
ROCE 9.15%
ROIC 7.3%
ROICexc 7.37%
ROICexgc 7.37%
OM 31.25%
PM (TTM) 23.8%
GM 82.52%
FCFM 22.35%
ROA(3y)11.08%
ROA(5y)8.7%
ROE(3y)17.66%
ROE(5y)14.37%
ROIC(3y)12.27%
ROIC(5y)9.93%
ROICexc(3y)12.9%
ROICexc(5y)10.44%
ROICexgc(3y)12.9%
ROICexgc(5y)10.44%
ROCE(3y)15.36%
ROCE(5y)12.44%
ROICexcg growth 3Y-7.45%
ROICexcg growth 5Y-19.44%
ROICexc growth 3Y-7.45%
ROICexc growth 5Y-19.44%
OM growth 3Y-19.39%
OM growth 5Y-9.76%
PM growth 3Y-15.14%
PM growth 5Y-9.04%
GM growth 3Y1.7%
GM growth 5Y3.22%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.29
Debt/FCF 2.83
Debt/EBITDA 1.02
Cap/Depr 97.39%
Cap/Sales 29.91%
Interest Coverage 250
Cash Conversion 84.33%
Profit Quality 93.91%
Current Ratio 1.13
Quick Ratio 1.08
Altman-Z 2.05
F-Score7
WACC8.04%
ROIC/WACC0.91
Cap/Depr(3y)110.23%
Cap/Depr(5y)116.61%
Cap/Sales(3y)28.94%
Cap/Sales(5y)29.44%
Profit Quality(3y)93.33%
Profit Quality(5y)92.4%
High Growth Momentum
Growth
EPS 1Y (TTM)10%
EPS 3Y-5.3%
EPS 5Y0.12%
EPS Q2Q%29.73%
EPS Next Y51.91%
EPS Next 2Y42.46%
EPS Next 3Y29.11%
EPS Next 5Y14.42%
Revenue 1Y (TTM)17.1%
Revenue growth 3Y16.53%
Revenue growth 5Y21.44%
Sales Q2Q%54.6%
Revenue Next Year40.56%
Revenue Next 2Y23.17%
Revenue Next 3Y16.63%
Revenue Next 5YN/A
EBIT growth 1Y19.58%
EBIT growth 3Y-6.06%
EBIT growth 5Y9.59%
EBIT Next Year238.86%
EBIT Next 3Y58.26%
EBIT Next 5Y31.69%
FCF growth 1Y-55.81%
FCF growth 3Y2.93%
FCF growth 5Y9.27%
OCF growth 1Y-35.85%
OCF growth 3Y18.8%
OCF growth 5Y14.09%